
PKR-IN-2
CAS No. 1628428-01-2
PKR-IN-2( —— )
Catalog No. M23724 CAS No. 1628428-01-2
PKR-IN-2 is a activator of pyruvate kinase (PKR).
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 277 | In Stock |
![]() ![]() |
10MG | 398 | In Stock |
![]() ![]() |
25MG | 656 | In Stock |
![]() ![]() |
50MG | 888 | In Stock |
![]() ![]() |
100MG | 1251 | In Stock |
![]() ![]() |
200MG | Get Quote | In Stock |
![]() ![]() |
500MG | Get Quote | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product NamePKR-IN-2
-
NoteResearch use only, not for human use.
-
Brief DescriptionPKR-IN-2 is a activator of pyruvate kinase (PKR).
-
DescriptionPKR-IN-2 is a activator of pyruvate kinase (PKR).
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptorpyruvate kinase
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1628428-01-2
-
Formula Weight468.57
-
Molecular FormulaC24H28N4O4S
-
Purity>98% (HPLC)
-
SolubilityDMSO:45mg/mL (96.04 mM; Need ultrasonic)
-
SMILESCC(C)CC(CC1)(CCN1C(c(cc1)ccc1NS(c1cccc2nccnc12)(=O)=O)=O)O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Popovici-Muller, et al. Preparation of N-(piperidinecarbonylphenyl) sulfonamide compounds as pyruvate kinase modulators. From PCT Int. Appl. (2014), WO2014139144A1 20140918.
molnova catalog



related products
-
Di-O-methylbergenin
Di-O-methylbergenin is a natural product for research related to life sciences.
-
Neoarctin B
Neoarctin B is a natural product of Arctium, Asteraceae. Neoarctin B can be used as a reference standard.
-
Oxyphyllacinol
Oxyphyllacinol has antidiarrheal activity.Oxyphyllacinol has been shown to treat dementia. Oxyphyllacinol was isolated from the S. nodiflora water fraction, while the S. nodiflora water fraction has been shown to have antioxidant and anti-aging activities, inducing mitochondrial activity and increasing ctt1 gene expression by regulating stress tolerance response.